跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Jardiance Duo - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Jardiance Duo
Approved
STANDARD
Jardiance Duo
Boehringer Ingelheim Hellas Single Member S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e4038c644dabcfac
Company
Boehringer Ingelheim Hellas Single Member S.A.
Type
Standard
Approval Details
Approval Id
e4038c644dabcfac
Drug Approval Philippines Name
Jardiance Duo
Product Name
Jardiance Duo
Registration Number
DR-XY47976
Brand Name
Jardiance Duo
Generic Name
Empagliflozin + Metformin hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
5 mg/1 g
Manufacturer
Boehringer Ingelheim Hellas Single Member S.A.
Importer
Boehringer Ingelheim (Philippines), Inc.
Company Detail Path
/organization/boehringer-ingelheim-hellas-single-member-s-a
Issuance Date
06 March 2025
Expiry Date
06 March 2030
Pharmacologic Category
Antidiabetic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e4038c644dabcfac
Type
Standard
Back to Philippines FDA Approvals